Annual Current Liabilities
$76.61 M
-$42.40 M-35.63%
December 31, 2024
Summary
- As of March 12, 2025, ABCL annual total current liabilities is $76.61 million, with the most recent change of -$42.40 million (-35.63%) on December 31, 2024.
- During the last 3 years, ABCL annual current liabilities has fallen by -$44.06 million (-36.51%).
- ABCL annual current liabilities is now -36.51% below its all-time high of $120.68 million, reached on December 31, 2021.
Performance
ABCL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$76.61 M
-$2.96 M-3.72%
December 31, 2024
Summary
- As of March 12, 2025, ABCL quarterly total current liabilities is $76.61 million, with the most recent change of -$2.96 million (-3.72%) on December 31, 2024.
- Over the past year, ABCL quarterly current liabilities has dropped by -$2.96 million (-3.72%).
- ABCL quarterly current liabilities is now -65.36% below its all-time high of $221.14 million, reached on June 30, 2022.
Performance
ABCL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ABCL Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.6% | -3.7% |
| 3 y3 years | -36.5% | -3.7% |
| 5 y5 years | +870.4% | -3.7% |
ABCL Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.5% | at low | -65.4% | +8.8% |
| 5 y | 5-year | -36.5% | +870.4% | -65.4% | +870.4% |
| alltime | all time | -36.5% | +1090.8% | -65.4% | +870.4% |
AbCellera Biologics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $76.61 M(-35.6%) | $76.61 M(-3.7%) |
| Sep 2024 | - | $79.57 M(+13.1%) |
| Jun 2024 | - | $70.38 M(-32.9%) |
| Mar 2024 | - | $104.88 M(-11.9%) |
| Dec 2023 | $119.01 M(+0.6%) | $119.01 M(+8.0%) |
| Sep 2023 | - | $110.24 M(-7.3%) |
| Jun 2023 | - | $118.91 M(+32.7%) |
| Mar 2023 | - | $89.59 M(-24.3%) |
| Dec 2022 | $118.32 M | $118.32 M(+11.6%) |
| Sep 2022 | - | $106.05 M(-52.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $221.14 M(+3.6%) |
| Mar 2022 | - | $213.42 M(+76.9%) |
| Dec 2021 | $120.68 M(+16.6%) | $120.68 M(+143.5%) |
| Sep 2021 | - | $49.55 M(-29.0%) |
| Jun 2021 | - | $69.76 M(-21.1%) |
| Mar 2021 | - | $88.39 M(-14.6%) |
| Dec 2020 | $103.49 M(+1210.8%) | $103.49 M(+414.8%) |
| Sep 2020 | - | $20.10 M(+154.6%) |
| Dec 2019 | $7.89 M(+22.7%) | $7.89 M |
| Dec 2018 | $6.43 M | - |
FAQ
- What is AbCellera Biologics annual total current liabilities?
- What is the all time high annual current liabilities for AbCellera Biologics?
- What is AbCellera Biologics annual current liabilities year-on-year change?
- What is AbCellera Biologics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for AbCellera Biologics?
- What is AbCellera Biologics quarterly current liabilities year-on-year change?
What is AbCellera Biologics annual total current liabilities?
The current annual current liabilities of ABCL is $76.61 M
What is the all time high annual current liabilities for AbCellera Biologics?
AbCellera Biologics all-time high annual total current liabilities is $120.68 M
What is AbCellera Biologics annual current liabilities year-on-year change?
Over the past year, ABCL annual total current liabilities has changed by -$42.40 M (-35.63%)
What is AbCellera Biologics quarterly total current liabilities?
The current quarterly current liabilities of ABCL is $76.61 M
What is the all time high quarterly current liabilities for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total current liabilities is $221.14 M
What is AbCellera Biologics quarterly current liabilities year-on-year change?
Over the past year, ABCL quarterly total current liabilities has changed by -$2.96 M (-3.72%)